EP4284796
CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.1.2022EP published:
16.4.2025EP application number:
22704232.2
EPO information:
European Patent Register
Max expiry date:
27.1.2042
Title in English:
CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDELanguage of the patent:
English
Timeline
Today
28.1.2022EP application
16.4.2025EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
ROSSO, Victor W.Address:
Princeton, New Jersey 08543, US
Priority
Number:
202163143769 PDate:
29.1.2021Country:
US
Classification
Categories:
C07D 403/12, A61K 31/501, A61P 29/00